These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8494598)

  • 1. Aminopyridazines--an alternative route to potent muscarinic agonists with no cholinergic syndrome.
    Wermuth CG
    Farmaco; 1993 Feb; 48(2):253-74. PubMed ID: 8494598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinomimetic activities of minaprine.
    Worms P; Kan JP; Steinberg R; Terranova JP; Perio A; Biziere K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):411-8. PubMed ID: 2586634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist.
    Schumacher C; Steinberg R; Kan JP; Michaud JC; Bourguignon JJ; Wermuth CG; Feltz P; Worms P; Biziere K
    Eur J Pharmacol; 1989 Jul; 166(2):139-47. PubMed ID: 2792188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.
    Kan JP; Steinberg R; Oury-Donat F; Michaud JC; Thurneyssen O; Terranova JP; Gueudet C; Souilhac J; Brodin R; Boigegrain R
    Psychopharmacology (Berl); 1993; 112(2-3):219-27. PubMed ID: 7871023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug.
    Bizière K; Kan JP; Souilhac J; Muyard JP; Roncucci R
    Arzneimittelforschung; 1982; 32(8):824-31. PubMed ID: 6890359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminopyridazines as acetylcholinesterase inhibitors.
    Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
    J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thienocycloheptapyridazines as new muscarinic agents.
    Barlocco D; Cignarella G; Fanelli F; Vitalis B; Matyus P; De Benedetti PG
    Drug Des Discov; 1997 Apr; 14(4):273-90. PubMed ID: 9197979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 3-(2-morpholinoethylamino)-4-methyl-6-phenyl pyridazine dihydrochloride (minaprine) on plasma cortisone levels of physostigmine treated rats.
    Laborit H; Bonifacj JF
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):63-7. PubMed ID: 6729250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and antidepressive effects of diaryl-4,6-amino-3-pyridazine analogs of minaprine].
    Coudert P; Rubat C; Couquelet JM; Bastide J
    Farmaco Sci; 1988 Oct; 43(10):793-800. PubMed ID: 3240830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonists.
    Rival Y; Hoffmann R; Didier B; Rybaltchenko V; Bourguignon JJ; Wermuth CG
    J Med Chem; 1998 Jan; 41(3):311-7. PubMed ID: 9464362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design of full agonists for the cortical muscarinic receptor.
    Saunders J; Freedman SB
    Trends Pharmacol Sci; 1989 Dec; Suppl():70-5. PubMed ID: 2694527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
    Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
    Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
    J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide.
    Pigini M; Brasili L
    Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.